Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Ivonescimab + Chemotherapy in Locally Advanced Cervical Cancer
NCT07244965Phase 2Not yet recruiting
- Sponsor
- Women's Hospital, Zhejiang University School of Medicine
- Start
- Dec 2025
- Primary completion
- Jul 2027
- Modality
- Antibody Conjugates, Bispecific Antibodies, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of ivonescimab in Cervical Cancer (CC), sponsored by Women's Hospital, Zhejiang University School of Medicine. Planned start Dec 2025; status: not yet recruiting.
02
Drugs
ivonescimab
03
Conditions
Cervical Cancer (CC)
Beyond the preview
Go deeper on NCT07244965.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07244965.